Zimbabwe is among the countries with relatively high pharmaceutical expenditure — 1.90 % GDP of GDP in 2026. This is explained by a large share of imported drugs and a weak local manufacturing base: the country purchases up to 70% of its medicines abroad, making the system vulnerable to exchange rate fluctuations. Major funding flows are directed toward the procurement of antiretroviral drugs and antimalarials, which are vital for the Zambezi valley and the lowlands of Manicaland. Zimbabwe ranks 21 out of 197 in this indicator.
Zimbabwe world ranking
Country position on the scale from last to first place for this indicator.
Change over time
Change in indicator over the available period.
Values — % GDP
Top countries by Pharmaceutical expenditure
Where Zimbabwe stands in the world ranking.
People also search for
Other pages of the reference by this indicator.